drugset / Trial / NCT06268054

Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea

NCT06268054 ↗

Phase 3 Not yet recruiting 78 enrolled EMS
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study if to evaluate the efficacy and safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea.

Timeline

Start
2025-02
Primary completion
2027-02
Completion
2027-09

Drugs

EvaluationDrugModalityDoseRoute
Subject DEH113 Unknown — —

Indications